From the PC to the PCC

By BIO-IT World
By Michael Athanas  Ph.D.

Sept 16, 2004 | A little more than a quarter-century ago, computing was transformed from the highly complex and specialized data center to the desktop in people's homes and offices in the form of the once-ubiquitous IBM 5150 (the first IBM PC) or Apple II. This, of course, was the beginning of a major techno-sociological transformation that eventually brought us to today's online casinos and the spam plague. Perhaps the pressures of history repeat as bioinformatics scientists are becoming more acquainted with personal compute clusters (PCCs).

We have all seen the overlay graph of chip transistor density and the growth rate of GenBank, where the GenBank curve rapidly accelerates past the transistor density curve. One may deduce that the power required to process genomic data is not keeping pace with data production. PCs are fast and getting faster, but will not likely surpass scientific computational demands with present silicon chip technology. For the most part, high-throughput computational biology processing takes place in the data center. From a computational biologist's perspective, we are still enslaved in the highly complex data center model, and we pretend to be happy about it.

A PCC is a loosely coupled, distributed computing platform that fits in or near a personal workspace. It has no special power requirements. Any supporting infrastructure, such as switches, UPS, and cabling, are preconfigured. The overall hardware is self contained and reasonably quiet.

The PCC must be preconfigured to enable the scientist the moment he or she pushes the "on" button. Just as the DOS prompt proved insufficient, the PCC must be an out-of-the-box scientific platform already loaded with base cluster-enabled applications. The platform must be secure, extensible, and able to integrate with other data/network resources.


1977 2004
Taking control: Like the revered Apple II, personal compute clusters such as the Apple Workgroup Cluster enable researchers to compute outside the total control of the data center.


PCCs must be priced so they fit within discretionary budgets of up-and-coming faculty or research staff who may be building a research group from scratch, such as Edward DeLong at MIT. PCCs are also used in bioinformatics teaching environments, such as Mike Thomas' lab at Idaho State University, to provide hands-on access to modern compute resources. In most cases, the target end-users are scientists, not IT administrators. Therefore, many of the administrative tasks involved in compute clusters must be encapsulated and simplified for non-IT professionals.

Several hardware vendors have recently become sensitive to this subtle PCC market pressure. Apple Computer again is the user-empowering trailblazer with its Apple Workgroup Cluster for Bioinformatics. This G5-Xserve-based cluster has succeeded in the category of ease-of-use and optimal design. This past February, Sun announced the release of its Sun Fire Starter Cluster, perhaps the most powerful and economical PCC solution currently available.

The most recent innovative PCC solution comes from a new company called Orion Multisystems. Orion has just announced the availability of its desktop cluster workstation — a 12-node integrated cluster architecture encapsulated in a single case slightly smaller than a common tower box. The machine uses less than 200 watts of power under maximum load from a standard power outlet and can be extended up to 48 nodes (or up to 96 nodes with the deskside system).

As an IT administrator, your scoff at the idea of a PCC may echo your predecessor's PC scoff uttered 25 years ago. Empowering computational scientists with (somewhat) scalable computing resources that supersede the power and economy of the most powerful workstations may be the next logical step. The creative scientific process sometimes runs a bit faster than the "on-demand" resource requisition bureaucracy in many large organizations. Scientists crave control of their own computational resources — perhaps toward distraction.



Michael Athanas is a founder of The BioTeam, which delivers scalable informatics solutions in collaboration with its partners, Apple, Sun, and Orion Multisystems. E-mail: michael@bioteam.net. 




White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.